Senzo Health has secured £1.4m in funding to further develop its Amplified Lateral Flow diagnostic technology.
SH
Senzo Health
Senzo Health develops high-accuracy point-of-care diagnostic technologies.
London, UK—Founded 2019
£1.4MTotal raised
Senzo Health is a life sciences company developing high-accuracy, low-cost diagnostic technologies for home and point-of-care settings. Its platform aims to deliver laboratory-grade performance through rapid testing formats.
Filed accounts
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from Senzo Health's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team

Jeremy Stackawitz
Jeremy brings leadership experience from SpeeDx and Quotient Limited. He previously served as chief executive officer of Senzo Health.
LinkedInFunding history
£1.4M